Feldan Therapeutics

Recent Finacing

Equity

Recent Raise

Undisclosed

Feldan Therapeutics develops the Feldan Shuttle, a patented peptide platform for intracellular delivery of biomolecules, advancing skin and pulmonary therapeutics including intralesional FLD-103 for basal cell carcinoma.

Founded 2007

Quebec, Canada

11-50

Private

feldan.com

Highlights

Focus Areas

Biotechnology

Therapeutics

Recent Investors

F

Financials

$29M

Total Raised

3

Funding rounds

9

Investors

Team

Upgrade to view the team

See the team members at Feldan Therapeutics.